Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „substrate“
Suchtreffer
Begriffe & Kennungen
Adasuve · 4.5 · In vitro studies indicated that loxapine was not a substrate for P-glycoprotein (P-gp), but does inhibit P-gp.
Eintrag öffnenAdasuve · 4.5 · In vitro studies indicated that loxapine was not a substrate for P-glycoprotein (P-gp), but does inhibit P-gp.
Eintrag öffnenAdasuve · 4.5 · Loxapine is a substrate for flavin-containing mono-oxygenases (FMOs), and for several CYP450 5 isozymes (see s
Eintrag öffnenAdasuve · 4.5 · Potential for other medicinal products to affect ADASUVE 17 Loxapine is a substrate for flavin-containing mono
Eintrag öffnenAdcetris · 4.5 · Co-administration of midazolam, a CYP3A4 substrate, with brentuximab vedotin did not alter the metabolism of m
Eintrag öffnenAdcirca (previously Tadalafil Lilly) · 4.5 · 24 P-glycoprotein substrates (e.g. digoxin) Tadalafil (40 mg once per day) had no clinically significant effec
Eintrag öffnenAdcirca (previously Tadalafil Lilly) · 4.5 · CYP1A2 substrates (e.g. theophylline) When tadalafil 10 mg was administered with theophylline (a non-selective
Eintrag öffnenAdcirca (previously Tadalafil Lilly) · 4.5 · CYP1A2 substrates (e.g. theophylline) When tadalafil 10 mg was administered with theophylline (a non-selective
Eintrag öffnenAdcirca (previously Tadalafil Lilly) · 4.5 · CYP2C9 substrates (e.g.R-warfarin) Tadalafil (10 mg and 20 mg) had no clinically significant effect on exposur
Eintrag öffnenAdcirca (previously Tadalafil Lilly) · 4.5 · CYP2C9 substrates (e.g.R-warfarin) Tadalafil (10 mg and 20 mg) had no clinically significant effect on exposur
Eintrag öffnenAdcirca (previously Tadalafil Lilly) · 4.5 · Endothelin-1 receptor antagonists (e.g. bosentan) Bosentan (125 mg twice daily), a substrate of CYP2C9 and CYP
Eintrag öffnenAdcirca (previously Tadalafil Lilly) · 4.5 · Endothelin-1 receptor antagonists (e.g. bosentan) Bosentan (125 mg twice daily), a substrate of CYP2C9 and CYP
Eintrag öffnenAdcirca (previously Tadalafil Lilly) · 4.5 · P-glycoprotein substrates (e.g. digoxin) Tadalafil (40 mg once per day) had no clinically significant effect o
Eintrag öffnenAdenuric · 4.5 · Desipramine/CYP2D6 substrates Febuxostat was shown to be a weak inhibitor of CYP2D6 in vitro. In a study in he
Eintrag öffnenAdenuric · 4.5 · Desipramine/CYP2D6 substrates Febuxostat was shown to be a weak inhibitor of CYP2D6 in vitro. In a study in he
Eintrag öffnenAdenuric · 4.5 · Rosiglitazone/CYP2C8 substrates Febuxostat was shown to be a weak inhibitor of CYP2C8 in vitro. In a study in
Eintrag öffnenAdenuric · 4.5 · Rosiglitazone/CYP2C8 substrates Febuxostat was shown to be a weak inhibitor of CYP2C8 in vitro. In a study in
Eintrag öffnenAdtralza · 4.5 · The effects of tralokinumab on the pharmacokinetics (PK) of CYP substrates, caffeine (CYP1A2), warfarin (CYP2C
Eintrag öffnenAfinitor · 4.5 · Everolimus is a substrate of CYP3A4, and also a substrate and moderate inhibitor of PgP. Therefore, absorption
Eintrag öffnenAkeega · 4.5 · CYP2C8 substrates Abiraterone is an inhibitor of CYP2C8. In a clinical study in healthy subjects, the AUC of p
Eintrag öffnen